Obalon Therapeutics OBLN possible retracementAfter a 4x gain in a day, my target for the possible retracement is usd5.4
Market Cap is still low, though: 64.341M
Please leave me a message if you want to test the buy and sell indicators that i am using.
Therapeutics
Esperion Therapeutics Analyst Ratings In February 2020, both Nexletol and Nexlizet were approved as oral treatments to lower LDL-C. Bempedoic acid remains in clinical trials of its efficacy in risk reduction for cardiovascular disease.
Esperion shares peaked last February, after the FDA approvals, but since then, the stock has declined. Shares are down 65% since their peak. (tipranks.com)
Analyst ratings:
11/10/2020 Credit Suisse Group $45.00
10/15/2020 Bank of America $52.00
9/29/2020 JPMorgan Chase & Co. $35.00
8/11/2020 Needham & Company LLC $158.00
8/10/2020 Stifel Nicolaus $75.00
Today`s price: usd27.71
Please leave me a message if you want to test the buy and sell indicators that i am using.
DNLI over 62.50After showing some incredible strength in November, DNLI is cooling off forming a bullflag. Over 62.50 should capture the next leg up.
Relief :)We love America, so when we heard yall needed some help with this Covid nonsense, my cuzins got on that. Relief Therapeutics Holdings AG, traded on the SIX, but also avaiable on OTC. I wont get to technical for all my american home boiz, but weve been injecting this stuff into our balls for years now, but we are more than happy to let yall use it to help youre lungs :)
OZSC.... buy
Why I am Long on $MMEDFRight now one of the stocks that have my attention, (partly because of Kevin O'Leary) and the rest of its history is Mind Medicine (MindMed Inc.) They are one of the first companies finding a way to neutralize LSD while working on a DMT based therapy drug. Also, the market cap and entry is low. This is one of those stocks where you need to dig deep into the pitch deck and look at competition, market opportunities, and entry price. Right now as a biotech company, it is one of my favorite low priced biotech stocks, and as a long hold in somebody's portfolio, I don't think the risk aversion is too high. That being said, everything I say is on an opinion based basis. Please proceed with caution and invest at your own risk. Do your own due diligence.
UMRX a top quarterly gainer,rising +850%.Expect Uptrend reversalUnum Therapeutics (UMRX, $3.32) was one of top quarterly gainers, jumping +850.2% to $3.32 per share. Tickeron A.I.dvisor analyzed 382 stocks in the Biotechnology Industry over the last three months, and discovered that 327 of them (85.6%) charted an Uptrend while 55 of them (14.4%) trended down. Tickeron A.I.dvisor found 51 similar cases when UMRX's price went up 15% within three months. In 51 out of those 51 cases, UMRX's price went down during the following month. Based on these historical data, Tickeron A.I. thinks the odds of an Uptrend reversal for UMRX are 90%.
The higher Bollinger Band was broken -- a price fall is expected as the ticker heads toward the middle band, which invites the trader to consider selling or shorting the ticker, or exploring put options. Tickeron AI shows that in 12 of 13 cases where UMRX's price broke its higher Bollinger Band, its price dropped further during the following month. The odds of a continued Downtrend are 90%.
RVVTF REVIVE THERAPEUTICS LTD upside potentialREVIVE THERAPEUTICS has a Market Capitalization of only 27.158M, while the Net Income (FY) reveals a debt, -1.028M.
Some analists predict an Average Target Price of 2.36 usd.
The indicators are bullish on most timeframes.
Still a lot of room to grow, with that huge volume.
If you are interested to test some amazing buy and sell indicators, which give the signal at the beginning of the candle, not at the end of it, like others, just leave me a P.M.
Soleno Therapeutics, Inc. (SLNO) __NASDAQPrices of Interest 🧐🤔:
$1.96
$2.37
$2.62
Profit prices to consider 🧐🤔:
$4.58
OVID Crossing Point The trend if this current pattern is about to be decided...
cross the red line sell!
Cross the green line short profit!
Share your Ideas in the comments below.
Sarepta Therapeutics $SRPT$SPRT is about to break the resistance of cup after a long consolidation. There are two options in front; one ise to break and to continue rising and the other one is forming a handle.
If you find my charts useful, please just leave me a "Like"
thx
Sorrento Therapeutics $SRNEUnconfirmed double bottom for $SRNE. It needs to break $2.66 for target price
If you find my charts useful, please just "Like"
TG Therapeutics $TGTX is on the top$TGTX is hitting the 5 years high. It did %65 in this week so far. RSI is still 66 on weekly and needs more for breakout. It may pull back before continues
BOLD Bump and runBold has seen some significant bullishness in the past weeks with a strong upward move, causing a golden cross, this is due to factors other than TA. (Beyond TA). This may be a 'bump' with a pullback occurring in the near future to the major trend.
100% Buy Signal on CRSPThe Megalodon indicators are giving us a buy signal on CRSP Therapeutics! The backtesting results are 100% on this stock so don't miss out on these profits!
The Megalodon indicator uses a machine learning algorithm, combined with data from over 500 buy setups, and over 2000 indicators to produce extremely accurate buy signals on any and all asset classes! You will also receive real time buy and sell signals for the stock market, cryptocurrency, as well as forex markets! We also busy completed our cryptocurrency automated trade bot. It trades for you, using our backtested indicator with phenomenal results! So try it today!!!
$AITB - AIT Therapeutics Inc - Buy AlertAIT Therapeutics Inc. is a clinical-stage biopharmaceutical company using nitric oxide (NO) to treat serious lung infections and pulmonary hypertension. The Company is currently applying its therapeutic expertise to treat lower respiratory tract infections that are not effectively addressed with current standards of care. AIT Therapeutics is advancing its revolutionary NO respiratory targeted system in clinical trials for the treatment of bronchiolitis and for nontuberculous mycobacteria (NTM). For more information, visit www.AIT-Pharm.com
